Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Jeng EK"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Autorzy:
Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Lee J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Osuna CE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Vikhe P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Schalk DR; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Chen E; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Fray E; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Kumar M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Schultz-Darken N; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Rakasz E; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Capuano S; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Ladd RA; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Gil HM; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Evans DT; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Jeng EK; Altor Biosciences, Miramar, FL 33027, USA.
Seaman M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Martin M; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Van Dorp C; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Perelson AS; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.; Santa Fe Institute, Santa Fe, NM 87501, USA.
Wong HC; Altor Biosciences, Miramar, FL 33027, USA.
Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Siliciano R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Safrit JT; ImmunityBio, Culver City, CA 90232, USA.
Nixon DF; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Soon-Shiong P; ImmunityBio, Culver City, CA 90232, USA.
Nussenzweig M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Whitney JB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 08; Vol. 383 (6687), pp. 1104-1111. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
Anti-Retroviral Agents*/pharmacology
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Acquired Immunodeficiency Syndrome*/therapy
Simian Immunodeficiency Virus*
Recombinant Fusion Proteins*/administration & dosage
Recombinant Fusion Proteins*/pharmacology
Animals ; Humans ; Broadly Neutralizing Antibodies/administration & dosage ; CD8-Positive T-Lymphocytes/virology ; Immunotherapy ; Macaca mulatta ; Viral Load ; Remission Induction ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice.
Autorzy:
Shrestha N; HCW Biologics Inc., Miramar, Florida, USA.
Chaturvedi P; HCW Biologics Inc., Miramar, Florida, USA.
Zhu X; HCW Biologics Inc., Miramar, Florida, USA.
Dee MJ; HCW Biologics Inc., Miramar, Florida, USA.
George V; HCW Biologics Inc., Miramar, Florida, USA.
Janney C; HCW Biologics Inc., Miramar, Florida, USA.
Egan JO; HCW Biologics Inc., Miramar, Florida, USA.
Liu B; HCW Biologics Inc., Miramar, Florida, USA.
Foster M; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Marsala L; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Wong P; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Cubitt CC; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Foltz JA; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Tran J; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Schappe T; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Hsiao K; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, Florida, USA.
Leclerc GM; HCW Biologics Inc., Miramar, Florida, USA.
You L; HCW Biologics Inc., Miramar, Florida, USA.
Echeverri C; HCW Biologics Inc., Miramar, Florida, USA.
Spanoudis C; HCW Biologics Inc., Miramar, Florida, USA.
Carvalho A; HCW Biologics Inc., Miramar, Florida, USA.
Kanakaraj L; HCW Biologics Inc., Miramar, Florida, USA.
Gilkes C; HCW Biologics Inc., Miramar, Florida, USA.
Encalada N; HCW Biologics Inc., Miramar, Florida, USA.
Kong L; HCW Biologics Inc., Miramar, Florida, USA.
Wang M; HCW Biologics Inc., Miramar, Florida, USA.
Fang B; HCW Biologics Inc., Miramar, Florida, USA.
Wang Z; HCW Biologics Inc., Miramar, Florida, USA.
Jiao JA; HCW Biologics Inc., Miramar, Florida, USA.
Muniz GJ; HCW Biologics Inc., Miramar, Florida, USA.
Jeng EK; HCW Biologics Inc., Miramar, Florida, USA.
Valdivieso N; HCW Biologics Inc., Miramar, Florida, USA.
Li L; HCW Biologics Inc., Miramar, Florida, USA.
Deth R; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, Florida, USA.
Berrien-Elliott MM; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Fehniger TA; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Rhode PR; HCW Biologics Inc., Miramar, Florida, USA.
Wong HC; HCW Biologics Inc., Miramar, Florida, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2023 May; Vol. 22 (5), pp. e13806. Date of Electronic Publication: 2023 Mar 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Senescence-Associated Secretory Phenotype*
Cellular Senescence*/genetics
Mice ; Animals ; Aging ; Inflammation ; Immunotherapy ; Phenotype
Czasopismo naukowe
Tytuł:
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.
Autorzy:
Jones RB; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.; Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts, United States of America.; Department of Microbiology Immunology and Tropical Medicine, The George Washington University, Washington, D.C., United States of America.
Mueller S; Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts, United States of America.
O'Connor R; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Rimpel K; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Sloan DD; Gilead Sciences, Foster City, California, United States of America.
Karel D; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Wong HC; Altor BioScience Corporation, Miramar, Florida, United States of America.
Jeng EK; Altor BioScience Corporation, Miramar, Florida, United States of America.
Thomas AS; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.; Department of Microbiology Immunology and Tropical Medicine, The George Washington University, Washington, D.C., United States of America.
Whitney JB; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Kovacs C; The Maple Leaf Medical Clinic, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Benko E; The Maple Leaf Medical Clinic, Toronto, Ontario, Canada.
Karandish S; Department of Microbiology Immunology and Tropical Medicine, The George Washington University, Washington, D.C., United States of America.
Huang SH; Department of Microbiology Immunology and Tropical Medicine, The George Washington University, Washington, D.C., United States of America.
Buzon MJ; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Lichterfeld M; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Irrinki A; Gilead Sciences, Foster City, California, United States of America.
Murry JP; Gilead Sciences, Foster City, California, United States of America.
Tsai A; Gilead Sciences, Foster City, California, United States of America.
Yu H; Gilead Sciences, Foster City, California, United States of America.
Geleziunas R; Gilead Sciences, Foster City, California, United States of America.
Trocha A; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
Ostrowski MA; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Li Ka Shing Medical Institute, St. Michael's Hospital, Toronto, Ontario, Canad.
Irvine DJ; Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.; Department of Biological Engineering, MIT, Cambridge, Massachusetts, United States of America.
Walker BD; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2016 Apr 15; Vol. 12 (4), pp. e1005545. Date of Electronic Publication: 2016 Apr 15 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
CD4-Positive T-Lymphocytes/*virology
HIV Infections/*immunology
Proteins/*pharmacology
T-Lymphocytes, Cytotoxic/*immunology
Virus Latency/*drug effects
Enzyme-Linked Immunosorbent Assay ; Enzyme-Linked Immunospot Assay ; Flow Cytometry ; Humans ; Polymerase Chain Reaction ; Recombinant Fusion Proteins ; Virus Activation/drug effects
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies